Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7919472 Enhanced antisense oligonucleotides

Patent 7919472 was granted and assigned to Ionis Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11879125 GalNAc compositions for improving siRNA bioavailability
0
Edits on 27 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 27 Nov, 2023
Edits made to:
Article (+407 characters)
Article

Patent abstract

Described herein are gap-widened antisense oligonucleotides having improved therapeutic index as compared to 5-10-5 MOE gapmer antisense oligonucleotides of the same sequence. Also described are methods of reducing a target RNA in an animal using the gap-widened antisense oligonucleotides of the present invention. Further, are methods for selecting a gap-widened antisense oligonucleotides.

Edits on 20 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 20 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11761951 Methods of selecting therapeutic molecules
Edits on 19 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 19 Sep, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Andrew M. Siwkowski0
Brett P. Monia0
Sanjay Bhanot0
Edits on 26 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 26 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=079194720
Edits on 22 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07919472 Enhanced antisense oligonucleotides US Patent 7919472 Enhanced antisense oligonucleotides

Infobox
Patent Number
079194720
Patent Number
79194720
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Ionis Pharmaceuticals
Ionis Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
079194720
Date of Patent
April 5, 2011
0
Patent Application Number
112312430
Date Filed
September 19, 2005
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=079194720
Patent Primary Examiner
‌
Jane Zara
0
Edits on 19 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07919472
Edits on 7 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07919472 Enhanced antisense oligonucleotides

Infobox
Is a
Patent
Patent
Current assignee
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07919472
Date of patent
April 5, 2011
Patent application number
11231243
Date Filed
September 19, 2005
Patent primary examiner
‌
Jane Zara

Find more entities like US Patent 7919472 Enhanced antisense oligonucleotides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo